Guo-Chong Chen1, Rhonda Arthur1, Li-Qiang Qin2, Li-Hua Chen2, Zhendong Mei3, Yan Zheng3, Yang Li1, Tao Wang1, Thomas E Rohan1, Qibin Qi4,5. 1. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY. 2. Department of Nutrition and Food Hygiene, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Soochow University, Suzhou, China. 3. State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China. 4. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY qibin.qi@einsteinmed.org. 5. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA.
Abstract
OBJECTIVE: To evaluate associations of oily and nonoily fish consumption and fish oil supplements with incident type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: We included 392,287 middle-aged and older participants (55.0% women) in the UK Biobank who were free of diabetes, major cardiovascular disease, and cancer and had information on habitual intake of major food groups and use of fish oil supplements at baseline (2006-2010). Of these, 163,706 participated in one to five rounds of 24-h dietary recalls during 2009-2012. RESULTS: During a median 10.1 years of follow-up, 7,262 incident cases of T2D were identified. Compared with participants who reported never consumption of oily fish, the multivariable-adjusted hazard ratios of T2D were 0.84 (95% CI 0.78-0.91), 0.78 (0.72-0.85), and 0.78 (0.71-0.86) for those who reported <1 serving/week, weekly, and ≥2 servings/week of oily fish consumption, respectively (P-trend < 0.001). Consumption of nonoily fish was not associated with risk of T2D (P-trend = 0.45). Participants who reported regular fish oil use at baseline had a 9% (95% CI 4-14%) lower risk of T2D compared with nonusers. Baseline regular users of fish oil who also reported fish oil use during at least one of the 24-h dietary recalls had an 18% (8-27%) lower risk of T2D compared with constant nonusers. CONCLUSIONS: Our findings suggest that consumption of oily fish but not nonoily fish was associated with a lower risk of T2D. Use of fish oil supplements, especially constant use over time, was also associated with a lower risk of T2D.
OBJECTIVE: To evaluate associations of oily and nonoily fish consumption and fish oil supplements with incident type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: We included 392,287 middle-aged and older participants (55.0% women) in the UK Biobank who were free of diabetes, major cardiovascular disease, and cancer and had information on habitual intake of major food groups and use of fish oil supplements at baseline (2006-2010). Of these, 163,706 participated in one to five rounds of 24-h dietary recalls during 2009-2012. RESULTS: During a median 10.1 years of follow-up, 7,262 incident cases of T2D were identified. Compared with participants who reported never consumption of oily fish, the multivariable-adjusted hazard ratios of T2D were 0.84 (95% CI 0.78-0.91), 0.78 (0.72-0.85), and 0.78 (0.71-0.86) for those who reported <1 serving/week, weekly, and ≥2 servings/week of oily fish consumption, respectively (P-trend < 0.001). Consumption of nonoily fish was not associated with risk of T2D (P-trend = 0.45). Participants who reported regular fish oil use at baseline had a 9% (95% CI 4-14%) lower risk of T2D compared with nonusers. Baseline regular users of fish oil who also reported fish oil use during at least one of the 24-h dietary recalls had an 18% (8-27%) lower risk of T2D compared with constant nonusers. CONCLUSIONS: Our findings suggest that consumption of oily fish but not nonoily fish was associated with a lower risk of T2D. Use of fish oil supplements, especially constant use over time, was also associated with a lower risk of T2D.
Authors: David S Siscovick; Thomas A Barringer; Amanda M Fretts; Jason H Y Wu; Alice H Lichtenstein; Rebecca B Costello; Penny M Kris-Etherton; Terry A Jacobson; Mary B Engler; Heather M Alger; Lawrence J Appel; Dariush Mozaffarian Journal: Circulation Date: 2017-03-13 Impact factor: 29.690
Authors: K A Abbott; T L Burrows; S Acharya; R N Thota; M L Garg Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2020-06-13 Impact factor: 4.006
Authors: O Kuda; T Jelenik; Z Jilkova; P Flachs; M Rossmeisl; M Hensler; L Kazdova; N Ogston; M Baranowski; J Gorski; P Janovska; V Kus; J Polak; V Mohamed-Ali; R Burcelin; S Cinti; M Bryhn; J Kopecky Journal: Diabetologia Date: 2009-03-11 Impact factor: 10.122
Authors: Eric B Rimm; Lawrence J Appel; Stephanie E Chiuve; Luc Djoussé; Mary B Engler; Penny M Kris-Etherton; Dariush Mozaffarian; David S Siscovick; Alice H Lichtenstein Journal: Circulation Date: 2018-05-17 Impact factor: 29.690
Authors: Keren I Hilgendorf; Carl T Johnson; Anja Mezger; Selena L Rice; Alessandra M Norris; Janos Demeter; William J Greenleaf; Jeremy F Reiter; Daniel Kopinke; Peter K Jackson Journal: Cell Date: 2019-11-21 Impact factor: 41.582
Authors: Jannike Øyen; Anne Lise Brantsæter; Ole Jakob Nøstbakken; Kåre I Birkeland; Margareta Haugen; Lise Madsen; Grace M Egeland Journal: Diabetes Care Date: 2021-08-18 Impact factor: 19.112
Authors: Jirapitcha Boonpor; Fanny Petermann-Rocha; Solange Parra-Soto; Jill P Pell; Stuart R Gray; Carlos Celis-Morales; Frederick K Ho Journal: Diabetes Obes Metab Date: 2022-04-25 Impact factor: 6.408